Gagnon Securities’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.8M | Buy |
|
|||||
|
2025
Q1 | $7.66M | Sell |
|
|||||
|
2024
Q4 | $6.06M | Buy |
|
|||||
|
2024
Q3 | $4.62M | Sell |
|
|||||
|
2024
Q2 | $17.1M | Buy |
|
|||||
|
2024
Q1 | $16M | Buy |
|
|||||
|
2023
Q4 | $18.4M | Sell |
|
|||||
|
2023
Q3 | $17.3M | Buy |
|
|||||
|
2023
Q2 | $22.4M | Sell |
|
|||||
|
2023
Q1 | $22.9M | Sell |
|
|||||
|
2022
Q4 | $21.8M | Sell |
|
|||||
|
2022
Q3 | $30.6M | Sell |
|
|||||
|
2022
Q2 | $34.7M | Sell |
|
|||||
|
2022
Q1 | $46.6M | Sell |
|
|||||
|
2021
Q4 | $36.9M | Buy |
|
|||||
|
2021
Q3 | $32M | Buy |
|
|||||
|
2021
Q2 | $30.3M | Buy |
|
|||||
|
2021
Q1 | $31.9M | Buy |
|
|||||
|
2020
Q4 | $26M | Buy |
|
|||||
|
2020
Q3 | $25.6M | Buy |
|
|||||
|
2020
Q2 | $22.1M | Buy |
|
|||||
|
2020
Q1 | $13.7M | Buy |
|
|||||
|
2019
Q4 | $17.5M | Sell |
|
|||||
|
2019
Q3 | $14.7M | Buy |
|
|||||
|
2019
Q2 | $12.1M | Buy |
|